Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders

6 May 2003

Abstract excerpt

Decreased expression of c-MPL protein in platelets, increased expression of polycythemia rubra vera 1 (PRV-1) and nuclear factor I-B (NFIB) mRNA in granulocytes, and loss of heterozygosity on chromosome 9p (9pLOH) were described as molecular markers for myeloproliferative disorders (MPDs). To assess whether these markers are clustered in subgroups of MPDs or represent independent phenotypic variations, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Chronic Myeloid Leukemia Treatments
Share to Myeloproliferative Neoplasms: Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 12730106
DOI: 10.1182/blood-2003-03-0744

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disordersPMID 12730106Read ↗

Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disorders.Semantic proximity Read ↗

Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietinSemantic proximity Read ↗

The Genetic Basis of Myeloproliferative DisordersSemantic proximity Read ↗

The chronic myeloproliferative disorders: clonality and clinical heterogeneity.Semantic proximity Read ↗

The Jak2V617F mutation, PRV-1 overexpression, and EEC formation define a similar cohort of MPD patients.Semantic proximity Read ↗

Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia.Semantic proximity Read ↗

Phenotypic variability within the JAK2 V617F-positive MPD: roles of progenitor cell and neutrophil allele burdens.Semantic proximity Read ↗

The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemiaSemantic proximity Read ↗

Clonal analyses define the relationships between chromosomal abnormalities and JAK2V617F in patients with Ph-negative myeloproliferative neoplasms.Semantic proximity Read ↗

JAK2-V617F-mutated myeloproliferative neoplasms reveal different allele burden within hematopoietic cell lineages: a microdissection study of bone marrow trephine biopsies.Semantic proximity Read ↗

Polycythemia vera and other primary polycythemias.Semantic proximity Read ↗

PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.